Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

MOVAPO

PALADIN LABS INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MOVAPO discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MOVAPO 10MG has been permanently discontinued (last updated October 16, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MOVAPO not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file1 product
Affected strength10MG
Last updated2023-10-16

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MOVAPO

PALADIN PHARMA INC.

10MG · DIN 02459140

Same strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02459132

Strength

10MG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

APOMORPHINE HYDROCHLORIDE

See all APOMORPHINE HYDROCHLORIDE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History